By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom today reported that its fourth-quarter revenues jumped 12 percent, driven by diagnostic services sales that more than doubled year over year.

The San Diego-based firm brought in total revenues of $15.5 million for the three-month period ended Dec. 31, compared to $13.8 million for the fourth quarter of 2010. It fell short of analysts' consensus expectation of $15.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.